The effect of ChABC on diffuse pathology is not restricted to tau pathology, because in a recent experiment ChABC was injected into the hippocampus of transgenic mice with an amyloidopathy model of neurodegenerative disease (APP/PSI mice), demonstrating restoration of fear memory and in increase in LTP (Vegh et al., 2014). Here, APP is linked to neurodegenerative disease.